Argent Trust Co’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Argent Trust Co's BIIB Position: Q4 2024 in Review
Argent Trust Co sold out of Biogen (BIIB) in Q4 2024, closing a stake of 1,200 shares — an estimated $233K sold.
Argent Trust Co first reported a position in BIIB in Q4 2014 and held it in 18 quarters. The position peaked at $392K in Q1 2015. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.
- Argent Trust Co reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
- Argent Trust Co sold 1,200 Biogen shares in Q4 2024, an estimated $233K.
- Argent Trust Co first reported a position in Biogen in Q4 2014 and held it in 18 quarters.
- Argent Trust Co's Biogen position peaked at $392K in Q1 2015.
- 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.
Based on Argent Trust Co's 13F filing for Q4 2024, filed 13 Feb 2025.